ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
547 hedge funds and large institutions have $39.7B invested in Alexion Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 255 increasing their positions, 157 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 71 | Existing positions closed: 84
65% less call options, than puts
Call options by funds: $164M | Put options by funds: $468M
Holders
547
Holding in Top 10
23
Calls
$164M
Puts
$468M
Top Buyers
| 1 | +$1.18B | |
| 2 | +$746M | |
| 3 | +$323M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$322M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$284M |
Top Sellers
| 1 | -$856M | |
| 2 | -$183M | |
| 3 | -$131M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$90.3M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$73.8M |